News & Publications

According to Article 48(2) of the Agreement on a Unified patent court (UPC Agreement), European patent attorneys (EPAs) may represent parties before the Unified Patent Court (UPC), provided they have appropriate...

Dr. Dirk Schüssler-Langeheine, attorney-at-law and partner in HOFFMANN EITLE's Patent Litigation & Licensing group, participated in an expert forum on questions of pharma and biotech litigation.

Michaela Ring, attorney-at-law (Germany) at HOFFMANN EITLE, has contributed an article entitled "Protection and Modes of Defense against Bad-Faith Trademark Filings" to the 2014 issue of the IP Global Expert Guide...

Morten Garberg of HOFFMANN EITLE's chemistry group discusses the novelty of numerical ranges in a patent claim in view of more recent decisions of the European Patent Office's Technical Boards of...

HOFFMANN EITLE provide a summary of key judgments in patent litigation with a particular focus on the UK and Germany, but also including case law from the Netherlands and Poland.

Dr. Bernd Kröger and Dr. Thorsten Bausch of HOFFMANN EITLE's chemistry group discuss a recent patent case in Germany concerning the pharmaceutical active ingredient known as leflunomide.

HOFFMANN EITLE provide a summary of key judgments on remaking, validity and infringement, with a particular focus on the UK and Germany.

Dr. Marco Retzlaff and Dr. Peter Klusmann of HOFFMANN EITLE's chemistry group provide an update on the EPO's current handling of "late-filed" facts and arguments before its Boards of Appeal.